190 related articles for article (PubMed ID: 12775229)
1. Colorectal cancer screening for the natural population of Beijing with sequential fecal occult blood test: a multicenter study.
Li S; Nie Z; Li N; Li J; Zhang P; Yang Z; Mu S; Du Y; Hu J; Yuan S; Qu H; Zhang T; Wang S; Dong E; Qi D
Chin Med J (Engl); 2003 Feb; 116(2):200-2. PubMed ID: 12775229
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of mass screening for colorectal cancer with 'sequential fecal occult blood test' in an asymptomatic population. Multicenter GI Research Group of Beijing Area of PLA].
Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):230-3. PubMed ID: 8261874
[TBL] [Abstract][Full Text] [Related]
3. [Preliminary report about the screening program for colorectal cancer by sequential fecal occult blood in Wuhan area for 4 years].
Lu ZM; Chen JG; Zhang YX; Wang Q; Xu J; Chen C; Yang R; Xiong F; Liu C; Peng XH
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Sep; 12(5):474-6. PubMed ID: 19742337
[TBL] [Abstract][Full Text] [Related]
4. A multicenter prospective study of immunochemical fecal occult blood testing for colorectal cancer detection.
Lohsiriwat V; Thavichaigarn P; Awapittaya B
J Med Assoc Thai; 2007 Nov; 90(11):2291-5. PubMed ID: 18181309
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of patients with clinically diagnosed colorectal cancer and those detected by mass screening.
Colorectal Cancer Cooperating Group, Beijing Society of Gastroenterology
Chin J Dig Dis; 2005; 6(1):26-30. PubMed ID: 15667555
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of three FOBT protocols for colorectal cancer screening in Chinese--a multicenter study].
Li SR; Wang HH; Hu JC; Li N; Liu YL; Wu ZT; Zheng Y; Wang HH; Wu K; Ye H
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(10):697-700. PubMed ID: 15932737
[TBL] [Abstract][Full Text] [Related]
7. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan.
Yang KC; Liao CS; Chiu YH; Yen AM; Chen TH
J Med Screen; 2006; 13 Suppl 1():S8-13. PubMed ID: 17227635
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the sensitivity of an immunochemical fecal occult blood test for colorectal neoplasia.
Yoshinaga M; Motomura S; Takeda H; Yanagisawa Z; Ikeda K
Am J Gastroenterol; 1995 Jul; 90(7):1076-9. PubMed ID: 7611200
[TBL] [Abstract][Full Text] [Related]
10. [Screening for colorectal cancer with an immunological fecal occult blood test].
Fernández JL; Gallegos M; Brochero A; Arévalo C; Piccioni H; Gutiérrez Galiana H
Acta Gastroenterol Latinoam; 1999; 29(2):73-8. PubMed ID: 10491719
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a selective screening for colorectal carcinoma: the Taiwan Multicenter Cancer Screening (TAMCAS) project.
Chen TH; Yen MF; Lai MS; Koong SL; Wang CY; Wong JM; Prevost TC; Duffy SW
Cancer; 1999 Oct; 86(7):1116-28. PubMed ID: 10506694
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer test use--Maryland, 2002-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(36):932-6. PubMed ID: 17851446
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16).
Chen LS; Liao CS; Chang SH; Lai HC; Chen TH
J Med Screen; 2007; 14(4):191-9. PubMed ID: 18078564
[TBL] [Abstract][Full Text] [Related]
14. [Features of colorectal cancer with fecal-occult-blood tests--comparison with colorectal cancer with no screening].
Takemasa I; Kikkawa N; Yasui M; Nishisho I; Fujitani K; Mishima H; Hasuike Y; Kobayashi K
Gan To Kagaku Ryoho; 1998 Aug; 25(10):1514-8. PubMed ID: 9725042
[TBL] [Abstract][Full Text] [Related]
15. Fecal occult blood testing: a false sense of security?
Schnell T; Aranha GV; Sontag SJ; Tode R; Reid S; Chejfec G; Karpf J; Levine G
Surgery; 1994 Oct; 116(4):798-802; discussion 802-3. PubMed ID: 7940181
[TBL] [Abstract][Full Text] [Related]
16. Population colorectal cancer screening with fecal occult blood test.
Rennert G; Rennert HS; Miron E; Peterburg Y
Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1165-8. PubMed ID: 11700264
[TBL] [Abstract][Full Text] [Related]
17. [Repeat mass screening for fecal occult blood for the diagnosis of colorectal neoplasms in a rural district. Results of an informational campaign].
Hofbauer F; Mach K; Egermann G
Wien Klin Wochenschr; 1991; 103(10):288-95. PubMed ID: 1858377
[TBL] [Abstract][Full Text] [Related]
18. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds.
Kronborg O; Jørgensen OD; Fenger C; Rasmussen M
Scand J Gastroenterol; 2004 Sep; 39(9):846-51. PubMed ID: 15513382
[TBL] [Abstract][Full Text] [Related]
19. [Screening of high-risk group with colorectal cancer].
Xu AG; Yu ZJ; Zhong XH; Gan AH; Liu JH; Luo QY
Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(2):116-8. PubMed ID: 20356496
[TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer screening among first-degree relatives of colorectal cancer patients: benefits and barriers.
Mack LA; Cook LS; Temple WJ; Carlson LE; Hilsden RJ; Paolucci EO
Ann Surg Oncol; 2009 Aug; 16(8):2092-100. PubMed ID: 19479307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
